智通财经APP获悉，中国国家药监局药品审评中心(CDE)网站最新公示，礼来(LLY.US)重磅药物GIP/GLP-1受体双重激动剂替尔泊肽注射液 ...

(LLY) has announced the appointment of Lucas Montarce as executive vice president and CFO and member of the company's Executive Committee, effective immediately. SentinelOne (S) has announced the ...

Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our P/B Growth Investor model based on the published strategy of ...

The pharma giant's financial results have been strong, largely thanks to its new crown jewel. But there may be more to come as the company's development pipeline looks incredibly exciting. Eli ...

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed yesterday at $935.02. According to ...

INDIANAPOLIS, Sept. 13, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 ...

Not only did NVO’s stock rise 4% in response to the positive news, shares of other drugmakers — Eli Lilly LLY, Viking Therapeutics VKTX and Structure Therapeutics GPCR — whose oral pills for ...

Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our P/B Growth Investor model based on the published strategy of ...